Ketamine Clinic Marketing: What Works When Google Ads Says No
Ketamine clinic marketing starts with one hard fact: most clinics cannot build their patient flow on Google Ads. Google restricts prescription drug terms in ads, landing pages and keywords, and in the US it only lets accredited online pharmacies and LegitScript-accredited telemedicine providers promote prescription drug services. An in-person infusion clinic usually fits neither. So the channel that fills chairs is the one you earn: Google search, Google Maps and the answers ChatGPT and AI Overviews give when someone asks about ketamine for depression. This guide shows the pages, signals and rules that decide who gets that patient.
Can a ketamine clinic advertise on Google?
Usually not in the way owners expect. Google’s healthcare and medicines policy states that it “restricts the use of prescription drug terms in ads, landing pages, and keywords.” For the United States, the policy names two kinds of advertiser that can promote prescription drug services: online pharmacies accredited by LegitScript, NABP or the .pharmacy programme, and telemedicine providers accredited by LegitScript’s Healthcare Merchant Certification Program. Both also need Google’s own certification.
An infusion clinic that treats patients in its own chairs is neither a pharmacy nor a telemedicine provider. Clinics try to work around this with ads that never say “ketamine”, such as “new depression treatment near you”. Those ads chase vaguer searches, and Google reviews the landing page too, so a page about ketamine can still trigger a disapproval.
| Who | Prescription drug services on Google Ads (US) |
|---|---|
| Online pharmacy | Allowed if accredited by LegitScript, NABP or .pharmacy, plus Google certification |
| Telemedicine provider | Allowed if accredited by LegitScript Healthcare Merchant Certification, plus Google certification |
| In-person ketamine clinic | No listed route in the US section of the policy |
One more moving part: the DEA has extended telemedicine flexibilities for prescribing controlled substances through 31 December 2026. That keeps at-home ketamine companies in the market, and many of them are certified and spending on ads. Your local clinic competes with their budgets in paid search, and beats them in local and organic search, where being a real place with a real medical team counts.
How patients search before they book
Nobody books an infusion series after one search. The person searching has often tried two or three antidepressants already, or is a family member searching on their behalf. They move through stages, and each stage is a different search with a different page behind it.
| Stage | What they type or ask AI | The page that wins it |
|---|---|---|
| Condition | treatment resistant depression options, PTSD treatment when therapy isn’t working | Condition pages written for that person, reviewed by your medical director |
| Treatment | does ketamine work for depression, ketamine vs Spravato, how many infusions | An honest treatment page and a ketamine versus Spravato comparison |
| Safety | ketamine infusion side effects, is ketamine addictive, who should not have ketamine | A safety and screening page: contraindications, monitoring, who is in the room |
| Cost | ketamine infusion cost, does insurance cover Spravato | A cost and insurance page with real ranges and what is included |
| Choice | ketamine clinic near me, best ketamine clinic in [city], reviews | Google Business Profile, location page, medical director profile |
Most clinic sites I review have a home page, one “ketamine therapy” page and a contact form. That covers the last row and leaves the first four to someone else, often a national telehealth brand or a news article. The patient who read their page first tends to book with them.
Ketamine or Spravato: the page most clinics get wrong
“Ketamine vs Spravato” is one of the most useful pages a clinic can publish, because it is the question patients bring to the consultation anyway. It is also where most sites blur the facts. Get these right:
- Spravato (esketamine) nasal spray is FDA approved for treatment-resistant depression, and in January 2025 it was approved as a monotherapy for adults with treatment-resistant depression. It is given under a REMS programme in certified treatment centres, with monitoring after each dose. It is often covered by insurance.
- Racemic ketamine given by IV infusion is FDA approved as an anaesthetic. Its use for depression is off-label, usually self-pay.
- Compounded ketamine for home use carries an FDA warning issued in October 2023 about use without monitoring. If your model is in-clinic, that supervision is a real difference worth explaining calmly.
A clinic that says “off-label” plainly looks more trustworthy, not less. It is also the version an AI system can quote without contradicting the FDA, which matters for the next section.
Running a ketamine or Spravato clinic? Send me your site and I will check which of these five search stages you show up for, on Google and in ChatGPT, before we speak. Get the free check or email bhagyashree@suroliamarketing.com.
What makes ChatGPT and AI Overviews name a clinic
When someone asks ChatGPT “who offers ketamine infusions for depression in Denver” the answer is assembled from pages it can retrieve and sources it trusts. From the clinics I see named and the ones I see skipped, the pattern is consistent:
- A named medical director with board certification, a profile page and the same name, title and credentials on your site, your Google profile and any directory listing.
- Facts AI can lift in one sentence: who you treat, the protocol (number of sessions, session length, monitoring), the price range and whether you are a certified Spravato centre. If the answer is buried in a PDF or a pop-up, it does not exist for retrieval.
- Agreement across the web. Address, phone, services and opening hours that match on your site, Google Business Profile and directories. Conflicting details make an AI less willing to recommend you.
- Third-party mentions. Local press, professional association directories, podcasts and referral partners. AI tools lean on what others say about you more than on what you say about yourself.
- Reviews that describe the experience, collected properly. Never offered for discounts and never filtered so only good ones get posted.
The claims that get clinics into trouble
The FTC’s Health Products Compliance Guidance expects health claims to be backed by competent and reliable scientific evidence. In ketamine marketing, these are the lines I remove on almost every site:
- “Up to 80% success rate” with no study named, or a study figure presented as your clinic’s result.
- “Relief in hours” as a promise rather than a description of what some patients in studies reported.
- Testimonials that imply everyone responds. Patient stories need context that results vary.
- “Cure” or “permanent” anywhere near depression, PTSD or addiction.
Tracking needs the same care. HHS guidance on online tracking technologies is the reason I keep ad pixels off intake, screening and booking pages. My setup is in the guide to HIPAA compliant Google Analytics.
What I build first for a ketamine clinic
- Google Business Profile done properly: the right primary category, real photos of the treatment rooms, services listed, and a review routine the front desk can run.
- Condition pages for the conditions you actually treat, each reviewed and dated by the medical director.
- Ketamine versus Spravato as described above, plus a Spravato page if you are a certified centre.
- Safety and screening: contraindications, vital signs monitoring, who sits with the patient, what happens after the session and the driving rule.
- Cost and insurance: price ranges, what a series includes, superbills, and which part insurance may cover.
- Medical director and team with Physician schema, linked from every treatment page as the reviewer.
- A page for referring therapists and psychiatrists explaining the referral process and how you share updates. Referrals are the channel competitors forget.
- Measurement without health data: calls and form starts tracked by page, no condition names sent to analytics.
This is the same patient-path method I use for every healthcare sector, described on my method page. For clinics in mental health more broadly, see mental health SEO.
Questions clinic owners ask me
Can I put the word ketamine in my Google Ads?
Google restricts prescription drug terms in ads, landing pages and keywords. In the US its policy lists accredited online pharmacies and LegitScript-accredited telemedicine providers as the advertisers allowed to promote prescription drug services. If your clinic is neither, plan on organic and local search as the main channel and check any ad plan against the current policy first.
Is ketamine FDA approved for depression?
Racemic ketamine is FDA approved as an anaesthetic, so using it for depression is off-label. Esketamine (Spravato) is the FDA-approved product for treatment-resistant depression and is given under a REMS programme in certified settings. Say this plainly on your site.
How long before SEO brings a ketamine clinic patients?
Local visibility on Maps can move within weeks once the profile, categories and reviews are right. Treatment and cost pages usually take a few months to rank, depending on how competitive your city is and how much trust the domain already has.
Should I list success rates?
Only figures you can support with competent and reliable evidence, with the source named. Published study results can be cited as study results. Your own clinic’s outcomes need proper data behind them, and testimonials must not imply typical results you cannot show.
Is this legal or medical advice?
No. It is how I apply advertising policies and published regulation to search work. Your counsel and medical director sign off on claims.
Sources
- Healthcare and medicines policy, Google Advertising Policies Help
- FDA warns patients and health care providers about potential risks associated with compounded ketamine, US FDA (October 2023)
- FDA approves Spravato as monotherapy, Healio (January 2025)
- Health Products Compliance Guidance, US Federal Trade Commission
- DEA extends telemedicine flexibilities for controlled substance prescribing through 2026, McDermott Will & Emery
- Use of online tracking technologies by HIPAA covered entities, US HHS
This article explains how I apply platform policies, published regulation and search guidelines to healthcare SEO. It is not legal or medical advice.
Written by Bhagyashree Surolia and checked against the sources above on the date shown. Read my editorial policy.
Want a second pair of eyes on your site?
A free 30-minute strategy call. I review your search footprint, local visibility and AI search presence before we speak, and tell you plainly what is achievable.
- You speak with me directly, always
- Your data stays private, never put into AI tools
- If SEO isn’t your bottleneck, I’ll say so